25450226|t|A2A adenosine receptor deletion is protective in a mouse model of Tauopathy.
25450226|a|Consumption of caffeine, a non-selective adenosine A2A receptor (A2AR) antagonist, reduces the risk of developing Alzheimer's disease (AD) in humans and mitigates both amyloid and Tau burden in transgenic mouse models. However, the impact of selective A2AR blockade on the progressive development of AD-related lesions and associated memory impairments has not been investigated. In the present study, we removed the gene encoding A2AR from THY-Tau22 mice and analysed the subsequent effects on both pathological (Tau phosphorylation and aggregation, neuro-inflammation) and functional impairments (spatial learning and memory, hippocampal plasticity, neurotransmitter profile). We found that deleting A2ARs protect from Tau pathology-induced deficits in terms of spatial memory and hippocampal long-term depression. These effects were concomitant with a normalization of the hippocampal glutamate/gamma-amino butyric acid ratio, together with a global reduction in neuro-inflammatory markers and a decrease in Tau hyperphosphorylation. Additionally, oral therapy using a specific A2AR antagonist (MSX-3) significantly improved memory and reduced Tau hyperphosphorylation in THY-Tau22 mice. By showing that A2AR genetic or pharmacological blockade improves the pathological phenotype in a Tau transgenic mouse model, the present data highlight A2A receptors as important molecular targets to consider against AD and Tauopathies. 
25450226	51	56	mouse	Species	10090
25450226	66	75	Tauopathy	Disease	MESH:D024801
25450226	92	100	caffeine	Chemical	MESH:D002110
25450226	131	140	 receptor	Gene	11540
25450226	128	131	A2A	DNAMutation	tmVar:c|SUB|A|2|A;HGVS:c.2A>A;VariantGroup:0;OriginalGene:11540;CorrespondingGene:135;CorrespondingSpecies:10090
25450226	142	146	A2AR	Gene	11540
25450226	191	210	Alzheimer's disease	Disease	MESH:D000544
25450226	212	214	AD	Disease	MESH:D000544
25450226	219	225	humans	Species	9606
25450226	245	252	amyloid	Disease	MESH:C000718787
25450226	282	287	mouse	Species	10090
25450226	329	333	A2AR	Gene	11540
25450226	377	395	AD-related lesions	Disease	MESH:D000544
25450226	411	429	memory impairments	Disease	MESH:D008569
25450226	508	512	A2AR	Gene	11540
25450226	518	521	THY	CellLine	CVCL:HF48
25450226	528	532	mice	Species	10090
25450226	628	646	neuro-inflammation	Disease	MESH:D007249
25450226	882	892	depression	Disease	MESH:D003866
25450226	965	974	glutamate	Chemical	MESH:D018698
25450226	975	999	gamma-amino butyric acid	Chemical	MESH:D005680
25450226	1043	1061	neuro-inflammatory	Disease	MESH:C536203
25450226	1158	1162	A2AR	Gene	11540
25450226	1175	1180	MSX-3	Chemical	-
25450226	1252	1255	THY	CellLine	CVCL:HF48
25450226	1262	1266	mice	Species	10090
25450226	1284	1288	A2AR	Gene	11540
25450226	1381	1386	mouse	Species	10090
25450226	1421	1424	A2A	DNAMutation	tmVar:c|SUB|A|2|A;HGVS:c.2A>A;VariantGroup:0;OriginalGene:11540;CorrespondingGene:135;CorrespondingSpecies:10090
25450226	1486	1488	AD	Disease	MESH:D000544
25450226	1493	1504	Tauopathies	Disease	MESH:D024801
25450226	Association	HGVS:c.2A>A;CorrespondingGene:135	MESH:D024801
25450226	Association	HGVS:c.2A>A;CorrespondingGene:135	MESH:D000544
25450226	Negative_Correlation	MESH:D002110	HGVS:c.2A>A;CorrespondingGene:135
25450226	Association	MESH:D008569	11540
25450226	Association	MESH:D000544	11540
25450226	Association	MESH:D024801	11540
25450226	Negative_Correlation	MESH:D002110	MESH:D000544
25450226	Negative_Correlation	MESH:D002110	11540
25450226	Negative_Correlation	MESH:D002110	MESH:C000718787
25450226	Association	MESH:D024801	135
25450226	Association	MESH:D000544	135

